Topics

Posted 9/11/2023, 3:15:00 AM

Neuroscience Antibodies and Assays Market to Grow Nearly $2 Billion by 2027, Driven by Neurological Disorders and Aging Population

The neuroscience antibodies and assays market is expected to grow by USD 1.83 billion from 2022 to 2027 at a CAGR of 9.44%.
North America is estimated to contribute 46% of the global market during the forecast period.
The market is driven by the rising prevalence of neurological disorders and an aging population.
The market is segmented by product (consumables and instruments), end-user (pharmaceutical and biopharmaceutical companies, academic and research institutes, and hospitals and diagnostic centers), and geography.
Key players include Abcam plc, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., and Cell Signaling Technology Inc. among others.

prnewswire.com

Relevant topic timeline:

8/22/2023

Global Markets for Artificial Intelligence in Drug Discovery

The global market for artificial intelligence (AI) in drug discovery is projected to grow significantly in the coming years, with emerging companies adding value and the increasing prevalence of chronic diseases driving demand, although limitations and a shortage of AI workforce may hinder growth.

8/23/2023

Nootropics Brain Supplements Market Size Set to Touch USD 8.2 Billion by 2032 with 9.5% CAGR

The global nootropics brain supplements market is projected to reach USD 8.2 billion by 2032, driven by rising adoption for memory enhancement, increasing research on neurodegenerative diseases, and growing emphasis on brain health and performance optimization.

8/24/2023

Ophthalmic Disease Therapeutics Market Set to Soar Past USD 53.8 Billion by 2030

The global Ophthalmic Disease Therapeutics Market is projected to reach USD 53.8 billion by 2030, with a CAGR of 6.10% in the forecast period, driven by factors such as the increasing prevalence of ophthalmic diseases and advancements in treatment options.

8/25/2023

Unraveling the Autoimmune Disease Diagnostics Market to 2030: Global Burden, Key Tests, and Geographic Dynamics

The global autoimmune disease diagnostics market is projected to reach $9.84 billion by 2030, with a CAGR of 7.2% driven by factors such as the increasing prevalence of autoimmune disorders and the growing emphasis on early diagnosis, though challenges such as complexity in diagnosing autoimmune diseases and an unfavorable reimbursement landscape remain.

8/27/2023

Artificial Intelligence in Genomics Market to hit USD 12.5 billion by 2032, says Global Market Insights Inc.

The global artificial intelligence in genomics market is projected to reach USD 12.5 billion by 2032, with a CAGR of 39.2% during the period 2023-2032, driven by the increasing adoption of AI in genomics research for analysis and personalized medicine.

9/1/2023

Neuromyelitis Optica Spectrum Disorder Market to grow by USD 173.48 million from 2022 to 2027

The global neuromyelitis optica spectrum disorder market is projected to grow at a CAGR of 6.16% from 2022 to 2027, driven by the growing geriatric population and increasing demand for neuromyelitis optica spectrum disorder drugs.

9/2/2023

Bone Replacement Market to grow by USD 5.611 billion from 2022 to 2027

The bone replacement market is projected to grow by USD 5.611 billion from 2022 to 2027, with North America accounting for 38% of the global market due to factors such as the adoption of advanced knee implants and the increasing number of knee and hip replacement surgeries in the region.

9/3/2023

The Dermatology Market to grow by USD 12.762 billion from 2022 to 2027

The global dermatology market is projected to grow by USD 12.76 billion from 2022 to 2027, with a CAGR of 10.82%, driven by the increasing prevalence of teledermatology and the growing demand for telemedicine, making dermatology care more accessible.

9/13/2023

Global Clinical Nutrition Products Market Size Grows Steadily, Driven by Major Players Like Bausch & Lomb and Regional Demand

The global Clinical Nutrition Products Market is expected to experience significant growth by 2031, with an estimated CAGR that will reach USD million.

9/24/2023

MICE Industry Set for Major Growth Despite Challenges

The global meetings, incentives, conventions, and exhibitions (MICE) market is projected to grow by USD 167 billion from 2022 to 2027, with North America leading in market share due to increased competitiveness in the travel industry and the growth of online portals.

9/25/2023

Gene Therapy Market Booming as Biotechs Develop Million-Dollar Treatments

Gene therapy companies like Sarepta and BioMarin are developing million-dollar treatments for severe genetic disorders, indicating a potential explosion in the gene therapy market. The global cell and gene therapy market is projected to reach approximately $82.24 billion by 2032.